Skip to content
AnalystLens

Labcorp Holdings 8-K Report, Material Agreement (Jan 31, 2025)

Reports
Material Agreements·Financial Events·Exhibits & Filings
Filing Date
Filed January 31, 2025
Period End
January 31, 2025
Security
LH
In the record · 2016–202610-K1310-Q338-K382

LH filed 13 annual reports (10-K), 33 quarterly reports (10-Q) and 382 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Sep ’17Sep ’17
  2. Auditor change8-K · Nov ’20Nov ’20
  3. Leadership change8-K · Oct ’22Oct ’22
  4. Leadership change8-K · Aug ’26Aug ’26

Summary

Summary of the 8-K filed January 31, 2025. Cited figures are marked; the original filing is the authoritative source.

On January 31, 2025, Labcorp Holdings Inc. entered into the First Amendment to its Receivables Purchase Agreement, among Labcorp Receivables LLC, Laboratory Corporation of America Holdings, PNC Bank, National Association as administrative agent, and the other parties, with the Company acknowledging and agreeing to the amendment.

The filing reports under Items 1.01 and 2.03 that the facility limit increased from $300 million to $700 milliona, a material expansion of the receivables financing arrangement. The amendment also changed the purchaser group. The Toronto-Dominion Bank joined as a committed purchaser with a scheduled commitment termination date of January 30, 2026.

MUFG Bank Ltd. and certain of its related conduit purchasers joined as purchasers, and their loans or investments may accrue interest at the CP Rate plus an applicable margin. The scheduled commitment termination date of August 23, 2027 and the interest terms for all other committed purchasers were not changed. The filing states that Labcorp Receivables is a separate legal entity with its own creditors, and its assets are not available to pay creditors of the Company or its subsidiaries other than Labcorp Receivables.

Collections in excess of amounts needed to repay purchasers and other Labcorp Receivables creditors may be remitted to the Company. The full terms are in Exhibit 10.1, which is incorporated by reference.

Key Highlights

  1. Facility limit under the Receivables Purchase Agreement increased from $300 million to $700 million.
  2. The Toronto-Dominion Bank joined as a committed purchaser, with a scheduled commitment termination date of January 30, 2026.
  3. MUFG Bank Ltd. and its Related MUFG Conduit Purchasers joined as purchasers, with interest at the CP Rate plus an applicable margin.
  4. The scheduled commitment termination date of August 23, 2027 for other committed purchasers was unchanged.
  5. Interest terms for all other purchasers, based on daily or term SOFR plus a 0.10% SOFR adjustment or a base rate plus an applicable margin, were unchanged.
  6. Labcorp Receivables is a separate legal entity, and its assets are not available to pay the Company's other creditors, though excess collections may be remitted to the Company.
  7. The amendment is filed as Exhibit 10.1, dated as of January 31, 2025.

Frequently Asked Questions

  1. What changed in the receivables financing facility?

    The facility limit was increased from $300 million to $700 million. The Toronto-Dominion Bank joined as a committed purchaser, and MUFG Bank Ltd. and its Related MUFG Conduit Purchasers joined as purchasers.

  2. When does The Toronto-Dominion Bank's commitment end?

    Its scheduled commitment termination date is January 30, 2026. The filing states that the August 23, 2027 termination date for all other committed purchasers was not changed.

  3. How are the MUFG-related purchasers paid?

    Loans or investments of the Related MUFG Conduit Purchasers may accrue interest at the CP Rate, as defined in the Receivables Purchase Agreement, plus an applicable margin.

  4. Can Labcorp Receivables' assets be used to pay Labcorp Holdings' creditors?

    No. The filing states that Labcorp Receivables is a separate legal entity with its own creditors, and its assets are not available to pay creditors of the Company or its subsidiaries other than Labcorp Receivables. Collections in excess of what is owed to purchasers and Labcorp Receivables creditors may be remitted to the Company.